U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H35ClN2O5S
Molecular Weight 439.01
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MIRINCAMYCIN

SMILES

[H][C@@]1(O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O)[C@H](NC(=O)[C@@H]2C[C@@H](CCCCC)CN2)[C@H](C)Cl

InChI

InChIKey=UFFIWDQGZCWMIU-YLKLGEPYSA-N
InChI=1S/C19H35ClN2O5S/c1-4-5-6-7-11-8-12(21-9-11)18(26)22-13(10(2)20)17-15(24)14(23)16(25)19(27-17)28-3/h10-17,19,21,23-25H,4-9H2,1-3H3,(H,22,26)/t10-,11+,12-,13+,14-,15+,16+,17+,19+/m0/s1

HIDE SMILES / InChI
Mirincamycin, a protein biosynthesis inhibitor was studied as an antibacterial agent. It was shown that mirincamycin could be promising candidate in the therapy and prophylaxis of multidrug-resistant falciparum malaria. Moreover, in combination with 4 or 8-aminoquinolines it could be used for the treatment and relapse prevention of vivax malaria. In addition, was studied the anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model. However, the negative P. cynomolgi hypnozoite data indicates that mirincamycin is unlikely to have potential as a clinical anti-relapse agent.

Approval Year

PubMed

PubMed

TitleDatePubMed
Enhancement of the curative activity of primaquine by concomitant administration of mirincamycin.
1985 Feb
In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon.
2010 Jan
Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum.
2011 Dec
Mirincamycin, an old candidate for malaria combination treatment and prophylaxis in the 21st century: in vitro interaction profiles with potential partner drugs in continuous culture and field isolates.
2014 Jun 10
Anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model.
2014 Oct 17
Name Type Language
MIRINCAMYCIN
INN  
INN  
Official Name English
1'-DEMETHYL-4'-DEPROPYL-4'-PENTYLCLINDAMYCIN
Common Name English
L-THREO-,ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(((4-PENTYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-
Common Name English
7-CHLORO-N-DEMETHYL-4'-PENTYLLINCOMYCIN
Common Name English
mirincamycin [INN]
Common Name English
Code System Code Type Description
ChEMBL
CHEMBL2110945
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
NCI_THESAURUS
C170184
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
PUBCHEM
76960025
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
CAS
19096-41-4
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
ALTERNATIVE
MESH
C000867
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
EPA CompTox
DTXSID301043385
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
SMS_ID
100000080645
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
CAS
31101-25-4
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
EVMPD
SUB08990MIG
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
INN
3558
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY
FDA UNII
F6T0FI8XCS
Created by admin on Fri Dec 15 18:22:48 GMT 2023 , Edited by admin on Fri Dec 15 18:22:48 GMT 2023
PRIMARY